{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:11:40Z","timestamp":1793391100573,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["AHA- 09CRP2251004"],"award-info":[{"award-number":["AHA- 09CRP2251004"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["WI215017"],"award-info":[{"award-number":["WI215017"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","award":["68633259"],"award-info":[{"award-number":["68633259"]}],"id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.jaut.2023.103029","type":"journal-article","created":{"date-parts":[[2023,3,28]],"date-time":"2023-03-28T18:51:48Z","timestamp":1680029508000},"page":"103029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis"],"prefix":"10.1016","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1065-1563","authenticated-orcid":false,"given":"George A.","family":"Karpouzas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Papotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R.","family":"Ormseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcella","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Adorni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Zimetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Ronda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2023.103029_bib1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/01.CIR.79.1.8","article-title":"High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies","volume":"79","author":"Gordon","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2023.103029_bib2","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jaut.2023.103029_bib3","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"dal-OUTCOMES Investigators, Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103029_bib4","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJMoa1609581","article-title":"ACCELERATE investigators, evacetrapib and cardiovascular outcomes in high-risk vascular disease","volume":"376","author":"Lincoff","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jaut.2023.103029_bib5","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/cells10030574","article-title":"High density lipoprotein cholesterol efflux capacity and atherosclerosis in cardiovascular disease: pathophysiological aspects and pharmacological perspectives","volume":"10","author":"Adorni","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jaut.2023.103029_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: a systematic review and meta-analysis","volume":"302","author":"Soria-Florido","year":"2020","journal-title":"Atherosclerosis"},{"issue":"Suppl","key":"10.1016\/j.jaut.2023.103029_bib7","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1194\/jlr.R800088-JLR200","article-title":"The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis","volume":"50","author":"Rader","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2023.103029_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.cca.2020.01.001","article-title":"Association of cholesterol uptake capacity, a novel indicator for HDL functionality, and coronary plaque properties: an optical coherence tomography-based observational study","volume":"503","author":"Oshita","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.jaut.2023.103029_bib9","doi-asserted-by":"crossref","first-page":"15093","DOI":"10.1073\/pnas.0704602104","article-title":"High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1","volume":"104","author":"Terasaka","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jaut.2023.103029_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cmet.2008.03.001","article-title":"HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis","volume":"7","author":"Tall","year":"2008","journal-title":"Cell Metabol."},{"key":"10.1016\/j.jaut.2023.103029_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0021-9150(98)00196-8","volume":"142","author":"Brown","year":"1999","journal-title":"Oxysterols Atherosclerosis, Atherosclerosis."},{"key":"10.1016\/j.jaut.2023.103029_bib12","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.113.301086","article-title":"Deficiency of ATP-binding cassette transporters A1 and G1 in macrophages increases inflammation and accelerates atherosclerosis in mice","volume":"112","author":"Westerterp","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.jaut.2023.103029_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/nrcardio.2015.124","article-title":"Dysfunctional HDL and atherosclerotic cardiovascular disease","volume":"13","author":"Rosenson","year":"2016","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.jaut.2023.103029_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1136\/annrheumdis-2012-202914","article-title":"Impaired serum cholesterol efflux capacity in rheumatoid arthritis and systemic lupus erythematosus","volume":"73","author":"Ronda","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103029_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072157","article-title":"Anti-atherogenic modification of serum lipoprotein function in patients with rheumatoid arthritis after tocilizumab treatment, a pilot study","volume":"9","author":"Greco","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.jaut.2023.103029_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12944-021-01444-6","article-title":"A meta-analysis of HDL cholesterol efflux capacity and concentration in patients with rheumatoid arthritis","volume":"20","author":"Xie","year":"2021","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.jaut.2023.103029_bib17","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/MOL.0000000000000256","article-title":"High-density lipoprotein function in rheumatoid arthritis","volume":"27","author":"Ormseth","year":"2016","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.jaut.2023.103029_bib18","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1136\/annrheumdis-2013-204806","article-title":"Hydrocortisone directly promotes cholesterol accumulation in macrophages","volume":"73","author":"Greco","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103029_bib19","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/art.41122","article-title":"Impact of cumulative inflammation, cardiac risk factors, and medication exposure on coronary atherosclerosis progression in rheumatoid arthritis","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2023.103029_bib20","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1136\/annrheumdis-2013-203617","article-title":"Prevalence, extent and composition of coronary plaque in patients with rheumatoid arthritis without symptoms or prior diagnosis of coronary artery disease","volume":"73","author":"Karpouzas","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103029_bib21","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jacc.2008.07.031","volume":"52","author":"Budoff","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2023.103029_bib22","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jcct.2014.07.003","article-title":"SCCT guidelines for the interpretation and reporting of coronary CT angiography: a report of the Society of Cardiovascular Computed Tomography Guidelines Committee","volume":"8","author":"Leipsic","year":"2014","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"10.1016\/j.jaut.2023.103029_bib23","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1161\/CIRCIMAGING.113.001047","article-title":"Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events","volume":"7","author":"Bittencourt","year":"2014","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.jaut.2023.103029_bib24","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/rheumatology\/key057","article-title":"High-sensitivity cardiac troponin I is a biomarker for occult coronary plaque burden and cardiovascular events in patients with rheumatoid arthritis","volume":"57","author":"Karpouzas","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.jaut.2023.103029_bib25","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jcct.2010.05.018","article-title":"Interobserver variations of plaque severity score and segment stenosis score in coronary arteries using 64 slice multidetector computed tomography: a substudy of the ACCURACY trial","volume":"4","author":"Pagali","year":"2010","journal-title":"J. Cardiovasc. Comput. Tomogr."},{"key":"10.1016\/j.jaut.2023.103029_bib26","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1007\/s10554-016-0957-2","article-title":"Dynamic change of high-risk plaque detected by coronary computed tomographic angiography in patients with subclinical coronary artery disease","volume":"32","author":"Iwasaki","year":"2016","journal-title":"Int. J. Cardiovasc. Imag."},{"key":"10.1016\/j.jaut.2023.103029_bib27","series-title":"Serum Cholesterol Loading Capacity on Macrophages Is Regulated by Seropositivity and C-Reactive Protein in Rheumatoid Arthritis Patients","author":"Karpouzas","year":"2022"},{"key":"10.1016\/j.jaut.2023.103029_bib28","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1002\/art.39039","article-title":"Newly identified antiatherosclerotic activity of methotrexate and adalimumab: complementary effects on lipoprotein function and macrophage cholesterol metabolism","volume":"67","author":"Ronda","year":"2015","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2023.103029_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.2174\/138920112799095383","article-title":"Cellular cholesterol efflux pathways: impact on intracellular lipid trafficking and methodological considerations","volume":"13","author":"Zanotti","year":"2012","journal-title":"Curr. Pharmaceut. Biotechnol."},{"key":"10.1016\/j.jaut.2023.103029_bib30","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2023.103029_bib31","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.jacc.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"60","author":"Thygesen","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2023.103029_bib32","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.jcmg.2012.03.009","article-title":"A long-term prognostic value of coronary CT angiography in suspected coronary artery disease","volume":"5","author":"Andreini","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.jaut.2023.103029_bib33","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.jcmg.2012.06.006","article-title":"Prognostic value of coronary CT angiography and calcium score for major adverse cardiac events in outpatients","volume":"5","author":"Hou","year":"2012","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.jaut.2023.103029_bib34","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1002\/art.41293","article-title":"Biologics may prevent cardiovascular events in rheumatoid arthritis by Inhibiting coronary plaque formation and stabilizing high-risk lesions","volume":"72","author":"Karpouzas","year":"2020","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2023.103029_bib35","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jacc.2016.10.029","article-title":"Intracoronary imaging, cholesterol efflux, and transcriptomes after intensive statin treatment: the YELLOW II study","volume":"69","author":"Kini","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jaut.2023.103029_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s13075-017-1311-3","article-title":"HDL cholesterol efflux capacity in rheumatoid arthritis patients: contributing factors and relationship with subclinical atherosclerosis","volume":"19","author":"Tejera-Segura","year":"2017","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2023.103029_bib37","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1093\/eurheartj\/ehv339","article-title":"Cholesterol efflux capacity in humans with psoriasis is inversely related to non-calcified burden of coronary atherosclerosis","volume":"36","author":"Salahuddin","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jaut.2023.103029_bib38","doi-asserted-by":"crossref","first-page":"e253","DOI":"10.1161\/ATVBAHA.119.313253","article-title":"Anti-inflammatory effects of HDL (high-density lipoprotein) in macrophages predominate over proinflammatory effects in atherosclerotic plaques","volume":"39","author":"Fotakis","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jaut.2023.103029_bib39","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1161\/CIRCULATIONAHA.117.032636","article-title":"Cholesterol efflux pathways suppress inflammasome activation, NETosis, and atherogenesis","volume":"138","author":"Westerterp","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jaut.2023.103029_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1161\/ATVBAHA.107.159467","article-title":"C-reactive protein inhibits cholesterol efflux from human macrophage-derived foam cells","volume":"28","author":"Wang","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jaut.2023.103029_bib41","doi-asserted-by":"crossref","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","article-title":"Role of C-reactive protein at sites of inflammation and infection","volume":"9","author":"Sproston","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jaut.2023.103029_bib42","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2022-002411","article-title":"Serum cholesterol loading capacity on macrophages is linked to coronary atherosclerosis and cardiovascular event risk in rheumatoid arthritis","volume":"8","author":"Karpouzas","year":"2022","journal-title":"RMD Open"},{"key":"10.1016\/j.jaut.2023.103029_bib43","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0022-2275(20)31999-4","article-title":"Cholesterol delivered to macrophages by oxidized low density lipoprotein is sequestered in lysosomes and fails to efflux normally","volume":"41","author":"Dhaliwal","year":"2000","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.jaut.2023.103029_bib44","doi-asserted-by":"crossref","first-page":"310","DOI":"10.21037\/cdt.2018.11.04","article-title":"Associations of ABCG1-mediated cholesterol efflux capacity with coronary artery lipid content assessed by near-infrared spectroscopy","volume":"9","author":"Takata","year":"2019","journal-title":"Cardiovasc. Diagn. Ther."},{"key":"10.1016\/j.jaut.2023.103029_bib45","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2021-220577","article-title":"Short-term dose and duration-dependent glucocorticoid risk for cardiovascular events in glucocorticoid-naive patients with rheumatoid arthritis","volume":"80","author":"Ocon","year":"2021","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jaut.2023.103029_bib46","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s12350-011-9428-2","article-title":"Comprehensive assessment of spotty calcifications on computed tomography angiography: comparison to plaque characteristics on intravascular ultrasound with radiofrequency backscatter analysis","volume":"18","author":"van Velzen","year":"2011","journal-title":"J. Nucl. Cardiol."},{"key":"10.1016\/j.jaut.2023.103029_bib47","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1093\/rheumatology\/keab642","article-title":"The impact of statins on coronary atherosclerosis progression and long-term cardiovascular disease risk in rheumatoid arthritis","volume":"61","author":"Karpouzas","year":"2022","journal-title":"Rheumatology"}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123000380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841123000380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T19:33:06Z","timestamp":1778700786000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841123000380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":47,"alternative-id":["S0896841123000380"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103029","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ATP-binding cassette G1 membrane transporter-mediated cholesterol efflux capacity influences coronary atherosclerosis and cardiovascular risk in Rheumatoid Arthritis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2023.103029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103029"}}